Drug trial for rare fetal blood disease shows promise for less invasive approach
Data from a new investigational drug that could alter the standard treatment for a rare blood disease suggests it has the potential to delay or prevent anemia and the need for intrauterine blood transfusions in babies who ...
Aug 7, 2024
0
5